Chronic diseases are among the most common causes of morbidity and mortality in the world. Chronic diseases can be controlled and their frequencies can be reduced through fight against risk factors such as obesity, smoking, and insufficient physical exercise; early diagnosis, and appropriate treatment. In this study, we aim to assess the medication adherence of individuals with chronic diseases. In this descriptive study, the sample includes individuals who have been diagnosed with chronic diseases and who have applied to a public hospital. The data collection is performed with a questionnaire form with questions on socio-demographic features and on the chronic illness, and with the Morisky Medication Adherence Scale-8. 68% of the patients who participated in the study were female and 32% of them were male. It has been found that 51.4% of the patients (5.35±2.5) had low medication adherence. For those patients who have stated that they got information regarding the treatment and who had high levels of belief that the treatment could help them control the disease, the medication adherence score was significantly higher (p
1. Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E, Hay SI, Mills EJ, Trickey A, Msemburi W, Coates MM. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980- 2015. Lancet Hiv. 2016;3:e361-87
2. Kharsany AB, Karim QA. HIV infection and AIDS in Sub-Saharan Africa: current status, challenges and opportunities. Open AIDS J. 2016;10:34.
3. UNAIDS. Report on the Global AIDS Epidemic. 2013. www.unaids.org/ sites/default/files/media.../UNAIDS_GlobalReportַ_2013 access date 27.03.2017
4. HIV/AIDS Ethiopia - WHO/Regional Office for Africa 2014. www.afro. who.int. access date 29.03.2017
5. Kumarasamy N, Solomon S, Chauguturu S, Cecelia A, Flanigan T, Mayer KH. The changing natural history of HIV disease before and after the introduction of generic antiretroviral therapy in Southern India. Clin Infect Dis. 2005;41:1525-8.
6. Kumarasamy N, Patel A and Pujari S. Antiretroviral therapy in Indian setting: When and what to start with, when & what to switch to? Review, Indian J Med Res. 2011;134:787-800.
7. Hammer SM. increasing choices for HIV therapy. N Engl J Med. 2002;346:2022-3.
8. Günthard HF, Aberg JA, Eron JJ, Hoy JF, Telenti A, Benson CA, Burger DM, Cahn P, Gallant JE, Glesby MJ, Reiss P. Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society–USA Panel. Jama. 2014;312(4):410-25.
9. Lima DGL, Arruda GE, Fonteles MM. Factors determining changes in initial antiretroviral therapy in Brazil. Rev Assoc Med Bras. 2012;58(2):222-8.
10. Monforte AD, Lepri AC, Rezza G, Pezzotti P, Antinori A, Phillips AN, Angarano G, Colangeli V, De Luca A, Ippolito G, Caggese L. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients. AIDS. 2000;14(5):499-507.
11. O’Brien ME, Clark RA, Besch CL, Myers L, Kissinger P. Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort in New Orleans, LA, USA. J Acquire Immune Defic Syndr. 2003;34:407-14.
12. Ammassari A. Self-reported symptoms and medication side effects influence adherence to HAART in persons with HIV infections. J Acquir Immune Deficit Syndr. 2001;28:445-9.
13. Sivadasan A. High rates of regimen change due to drug Toxicity among Cohort of South Indian Adults with HIV Infection Initiated on Generic, First-Line Antiretroviral Treatment. J Assoc Physicians India. 2009;57:384-8.
14. Woldemedhin B, Wabe NT. The Reason for Regimen Change among HIV/AIDS Patients Initiated on First Line Highly Active Antiretroviral Therapy in Southern Ethiopia. N Am J Med Sci. 2012;4(1):19-23.
15. Wube M, Tesfaye A, Hawaze S. Antiretroviral Therapy Regimen Change Among HIV/AIDS Patients in Nekemt Hospital: a Primary Care Hospital in Oromia Regional State, Ethiopia. J App Pharm Sci. 2013;3(8):036- 040.
16. Hart E, Curtis H, Wilkins E, Johnson M. National review of first treatment change after starting highly active antiretroviral therapy in antiretroviral naïve patients in North Manchester General Hospital, Manchester, UK. HIV Med. 2007;8:186–91.
17. Mess OU, Eupene N, Anglaret Y. Antiretroviral treatment changes in adults from Cote d’lvoire: The role of tuberculosis and pregnancy. AIDS. 2010;24:93–9.
18. Kiguba R, Byakika-Tusiime J, Karamagi C, Ssali F, Mugyenyi P, Katabira E. Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors. J Acquir Immune Defic Syndr. 2007;45:218-23.
19. Petros T, Amelo W, Tesema S. Reasons for art regimen change among patients on HAART at Durame hospital, Ethiopia. MD-Medical Data. 2015;7:201-5.